Primary Headache Epidemiology in Children and Adolescents: a Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Introduction: Headache is the most prevalent neurological manifestation in adults and one of the leading causes of disability worldwide. In children and adolescents, headaches are arguably responsible for a remarkable impact on physical and psychological issues, yet high-quality evidence is scarce.
Material And Methods: We searched cross-sectional and cohort studies in Embase, Medline, Web of Science, and Cochrane databases from January 1988 to June 2022 to identify the prevalence of headaches in 8-18 years old individuals. The risk of bias was examined with the Joanna Briggs Institute (JBI) scale. A random-effects model was used to estimate the pooled prevalence of pediatric headache. Subgroup analyses based on headache subtypes were also conducted.
Results: Out of 5,486 papers retrieved electronically, we identified 48 studies that fulfilled our inclusion criteria. The pooled prevalence of primary headaches was 11% for migraine overall [95%CI: 9-14%], 8% for migraine without aura (MwoA) [95%CI: 5-12%], 3% for migraine with aura (MwA) [95%CI:2-4%] and 17% for tension-type headache (TTH) [95% CI: 12-23%]. The pooled prevalence of overall primary headache in children and adolescents was 62% [95% CI: 53-70%], with prevalence in females and males of 38% [95% CI: 16-66%] and 27% [95% CI: 11-53%] respectively. After the removal of studies ranked as low-quality according to the JBI scale, prevalence rates were not substantially different. Epidemiological data on less common primary headaches, such as trigeminal autonomic cephalalgias, were lacking.
Conclusion: We found an overall remarkably high prevalence of primary headaches in children and adolescents, even if flawed by a high degree of heterogeneity. Further up-to-date studies are warranted to complete the picture of pediatric headache-related burden to enhance specific public interventions.
Waliszewska-Prosol M, Grandi G, Ornello R, Raffaelli B, Straburzynski M, Tana C Neurol Ther. 2025; .
PMID: 40085393 DOI: 10.1007/s40120-025-00720-2.
Weng S, Xiao X, Liang S, Xue Y, Yang X, Ji Y BMJ Open. 2025; 15(3):e092692.
PMID: 40074270 PMC: 11904329. DOI: 10.1136/bmjopen-2024-092692.
Gazerani P Curr Pain Headache Rep. 2025; 29(1):57.
PMID: 40029442 PMC: 11876209. DOI: 10.1007/s11916-025-01366-3.
Pratile D, Orlandi M, Carpani A, Mensi M Pediatr Rep. 2025; 17(1).
PMID: 39997628 PMC: 11858191. DOI: 10.3390/pediatric17010021.
Krivoshein G, Rivera-Mancilla E, MaassenVanDenBrink A, Giniatullin R, van den Maagdenberg A J Headache Pain. 2025; 26(1):40.
PMID: 39994546 PMC: 11853570. DOI: 10.1186/s10194-025-01966-9.